Ellen DeGeneres Resigns in American Idol – Contrave Promises Weight Loss

By Conrad Abellanosa at 30 July, at 08 : 23 AM

Ellen DeGeneres Resigns in American Idol What is happening to the judges of American Idol, first Paula Abdul, then Simon Cowell then now Ellen DeGeneres?

After just one season, talk show host Elle DeGeneres is leaving the judges’ table of American Idol. She said in her Twitter account yesterday: “I’ve voted myself off American Idol.” It turns out that she informed the producers months before that she’s leaving. She felt like it wasn’t the right “fit for her,” and that her schedule became “more than she bargained for” and that she loves discovering, nurturing and supporting young talents but it was difficult for her to judge them and end up hurting their feelings.

The American Idol producers understood her situation and support her decision, in their statement they said “she brought honest and optimism to our judging panel and I will miss her greatly,” said Simon Fuller AI’s creator and executive producer. For Network Groups was also saddened by her decision to leave the show “we were fortunate to receive the humor, energy and love for talent that she brought to the show,” said Peter Rice, Fox Network Groups, Chairman of Entertainment. We wonder who will replace the Simon and Ellen. Will this be the last season of Idol? We hope not!

We go to another health story, a new supplement promises weight loss but it is still on its experimental stage.

Orexigen’s experimental drug Contrave is designed to reduce cravings. Volunteers who took the said supplement lost a total of 13 pounds in a year. They felt less craving for sweet and starchy food. They even felt fuller that they didn’t have to fulfill their cravings.

The study was published in Lancet medical journal. The study showed side effects but was mild and went away over time. So this might be an auspicious future for Contrave. Nonetheless, experts still claim that a further study must be done to make sure that it is safe.

The data of the said study has already been presented to the U.S. Food and Drug Administration. It is scheduled for approval in December.
Contrave is a mixture of the antidepressant bupropion, a generic version of GlaxoSmithKline’s Wellbutrin, and naltrexone, used to treat alcoholism and other addictions.

Now, this is something that weight conscious people will have to look forward for. Many weight loss supplements are now flooding the market but most of them promise the same thing—weight loss. Yes they are maybe effective but they are relatively costly. Let’s just wait and hold on to our seats as we wait for the release of this another weight loss supplement. I only hope that it won’t cost that much.